Abstract
AbstractCocaine use disorder represents a public health crisis with no FDA-approved medications for its treatment. A growing body of research has detailed the important connections between the brain and the resident population of bacteria in the gut, the gut microbiome in psychiatric disease models. Acute depletion of gut bacteria results in enhanced reward in a mouse cocaine place preference model, and repletion of bacterially-derived short-chain fatty acid (SCFA) metabolites reverses this effect. However, the role of the gut microbiome and its metabolites in modulating cocaine-seeking behavior after prolonged abstinence is unknown. Given that relapse prevention is the most clinically challenging issue in treating substance use disorders, studies examining the effects of microbiome manipulations in relapse-relevant models are critical. Here, Sprague-Dawley rats received either untreated water or antibiotics to deplete the gut microbiome and its metabolites. Rats were trained to self-administer cocaine and subjected to either within-session threshold testing to evaluate motivation for cocaine or 21 days of abstinence followed by a cue-induced cocaine-seeking task to model relapse behavior. Microbiome depletion did not affect cocaine acquisition on an FR1 schedule. However, microbiome-depleted subjects exhibited significantly enhanced motivation for low dose cocaine on a within-session threshold task. Similarly, microbiome depletion increased cue-induced cocaine-seeking following prolonged abstinence. In the absence of a normal microbiome, repletion of bacterially-derived SCFA metabolites reversed the behavioral and transcriptional changes associated with microbiome depletion. These findings suggest that gut bacteria, via their metabolites, are key regulators of drug-seeking behaviors, positioning the microbiome as a potential translational research target.
Publisher
Cold Spring Harbor Laboratory
Reference65 articles.
1. Substance Abuse and Mental Health Services Administration. Facing Addiction in America: The Surgeon General’s Report on Alcohol, Drugs, and Health. in Facing Addiction in America: The Surgeon General’s Report on Alcohol, Drugs, and Health (ed. U.S. Department of Health and Human Services (HHS), O. of the S. G .) chap. 6 (HHS, 2016). doi:https://www.ncbi.nlm.nih.gov/books/NBK424857/pdf/Bookshelf_NBK424857.pd.
2. Cross-talk between the epigenome and neural circuits in drug addiction
3. Neuroepigenetics and addiction;Handbook of clinical neurology,2018
4. Neuroimmune mechanisms of psychostimulant and opioid use disorders
5. The role of gut-immune-brain signaling in substance use disorders